Simulations Plus, Inc.

NASDAQ:SLP

Medical - Healthcare Information Services

Healthcare
$18.50 +0.11%

+$0.02 today

Market cap
$374.16M
Beta
1.32
P/E (TTM)
-5.9
EPS (TTM)
-$3.12
52W Low $11.09High $21.01

Volume 0.00M

Average 0.35M

SLP Purchases of Investments

Cash used to buy marketable securities and other investments.

Simulations Plus, Inc.NASDAQ: SLP

Purchases of Investments · Q2 FY2026 · quarter ended Feb 2026

Purchases of investments growth accelerates

Q2 FY2026 purchases of investments of $10.52M (cash outflow) rose 601.1% year over year, ahead of the +23.8% change in trailing-twelve-month purchases of investments. Sequentially, it rose 91.2% from the prior quarter. Over 3 fiscal years it compounded at -59.9% a year.

Context

  • Purchases of investments amounted to 8.2% of revenue in FY2025, down 87.7 pp from a year earlier.
  • Purchases of investments grew in size in 0 of the last 3 fiscal years.
  • FY2025 was the smallest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +601.1% holds above the trailing-twelve-month pace of +23.8%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterFeb 2026
-$10.52M+91.2% QoQ
Last fiscal yearAug 2025
-$6.5M-90.3% YoY
LTMFeb 2026
-$17.52M+23.8% YoY
Purchases of Investments past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+601.1%——
1 year-90.3%——
3-year CAGR-59.9%——
5-year CAGR——
10-year CAGR——

Purchases of Investments history

USD · from the cash flow

Latest · FY2025
(6.5M) USD
Year-over-year change
+90.3%

Purchases of Investments vs competitors

How SLP compares with its peers on the latest reported figures

  • Peers report in different currencies, so purchases of investments is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +23.8% is the 3rd highest of 5, against a peer median of -17.0%.
  • Purchases of investments amounts to 21.7% of revenue for SLP, versus a peer median of 0.2%.
SLP Competitors
Purchases of Investments for SLP and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CLLSCellectis S.A.LTM Mar 2026$229.48M USD+38.2%—337.0%
KRROKorro Bio, Inc.LTM Mar 2026$71.41M USD+43.1%-11.1%1858.6%
DHDefinitive Healthcare Corp.LTM Mar 2026$64.57M USD-72.2%-42.6%27.1%
SLPSimulations Plus, Inc.LTM Feb 2026$17.52M USD+23.8%-59.9%21.7%
AGLAgilon Health, Inc.LTM Mar 2026$12.64M USD-78.8%-49.2%0.2%
SOPHSOPHiA GENETICS S.A.LTM Mar 2026$1.44M USD—-58.4%1.8%
ANROAlto Neuroscience, Inc.LTM Mar 2026$0 USD———
NRCNational Research CorporationLTM Mar 2026$0 USD——0.0%
ACIUAC Immune S.A.LTM Dec 2025CHF 0 CHF——0.0%
NAKANakamoto Inc.LTM Mar 2026$0 USD——0.0%
OPRXOptimizeRx CorporationLTM Mar 2026$0 USD——0.0%
Peer median (excluding SLP) —-17.0%-45.9%0.2%

Competitors are the stored peer set for SLP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Aug 2021
FY2022
Aug 2022
FY2023
Aug 2023
FY2024
Aug 2024
FY2025
Aug 2025
Net Income9.78M12.48M9.96M9.95M(64.72M)
Depreciation & Amortization3.59M3.57M3.84M5.67M8.21M
Deferred Income Tax(628K)(270K)(2.1M)(1.77M)(5.43M)
Stock-Based Compensation2.75M3.04M4.83M6.54M6.35M
Change in Working Capital974K(2.62M)5.1M(4.21M)(2.59M)
Accounts Receivables(2.43M)(3.94M)4.1M3.13M(581K)
Inventory3.15M0000
Accounts Payables39K(162K)(81K)(477K)(132K)
Other Working Capital210K1.48M1.09M(6.86M)(1.87M)
Other Non-Cash Items2.74M1.7M219K(2.86M)76.29M
Operating Cash Flow19.2M17.9M21.86M13.32M18.13M
Capital Expenditures(4.58M)(3.97M)(4.27M)(566K)(713K)
Acquisitions (Net)2.95M3.15M(8.22M)(98.77M)0
Purchases of Investments(122.4M)(100.85M)(95.05M)(67.16M)(6.5M)
Sales of Investments100.23M109.12M114.91M116.27M15.01M
Other Investing Activities(2.95M)(3.15M)(3.82M)(3.74M)(4.24M)
Investing Cash Flow(26.74M)4.31M7.37M(53.97M)3.56M
Debt Repayment00000
Common Stock Issued1.46M891K0731K430K
Common Stock Repurchased00(20M)00
Dividends Paid(4.81M)(4.85M)(4.81M)(4.8M)0
Other Financing Activities(1.33M)(3.67M)1.54M(2.5M)(1.58M)
Financing Cash Flow(4.68M)(7.62M)(23.27M)(6.57M)(1.15M)
Effect of Forex Changes00000
Net Change in Cash(12.22M)14.58M5.96M(47.21M)20.54M
Free Cash Flow14.63M13.93M17.58M12.75M17.41M

Simulations Plus, Inc.

NASDAQ:SLP

Intrinsic Alpha fair value

Locked

Current Price

$18.50

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.